Upload
kim-solez-
View
464
Download
2
Embed Size (px)
Citation preview
Dawn of Tissue Engineering Pathology and
The End of Transplantation Waiting Lists
Current Problem
Donor organ transplant currently gold standard for end stage organ failure
BUTThis only provides new organs to 10% of
patients in need
Current Problem
Thousands of patients die without ever having a chance for transplant
Solution:Tissue Engineered Organs
Functional organs made from stem cellsWill completely eliminate need for donor
organs
TE organs = 100% availability of organ transplantation for everyone in need
Future Has Arrived
Current Successes of TE Organs- Semi Synthetic Scaffolds used in
Tracheobronchial transplantation,- Esophagus, Bladder transplant- Viacyte VC-01 Combination product used to
replace pancreas in Type 1 Diabetes Patients
Success of TE
Provide more opportunity for this
Critical Role of Pathologists in TE field
TE organs won't always come out perfectPathologists must identify abnormalities
Types of Abnormalities
“One off” abnormalities. Seen only once, caused by certain engineering techniques
Repeating abnormalities will form the bulk of what Pathologists see and look for
Repeating Abnormalities
Repeating Abnormalities Missing Cells/Structures, Loop of Henle missing
Chang C.H. &
Davies J.A. kidneys
from re-aggregated fetal cells fetal cells
Rejection Unlikely
Since patients own stem cells are being used, TE organ will be syngeneic
But Don't Forget
TE Organs will be subject to conventional diseases too
Therefore Pathologists will have double the number of diagnostic possibilities when it comes to TE organs!
Classifying TE Pathologies
Classification based on abnormalities and their ability to disrupt TE organ function
Benign criteria vs Potentially Lethal Criteria
Benign Criteria
Will not severely affect TE organ function or will not affect organ at all.
Will be safe to use TE organ in patient
Potentially Lethal Criteria
Severely affects TE organ function. Cause acute/chronic TE organ failureDeemed unfit for transplantation into patient
Use of Point System
Benign Criteria (-) pointsPotentially Lethal Criteria (+) points Sum of points = Class variantPoint threshold for “Danger Zone,”
“Borderline,” “Safe Zone,” etc.
Algorithms for Quantifiable Data
Tissue Engineering Medicine will offer true quantification
Biomarkers are quantifiable by nature Morphometry now a feasible way to assess
tissue
Algorithms for Quantifiable Data
Arbitrary scales will no longer be used. Computers can now create classification
algorithms from “Big Data” mining programs Previous classifications (I.E. Banff
Classification) were only semi quantifiable and therefore relied on subjective discretion of Pathologists
Assessing TE Organ Health with Surrogate Markers
Physically cutting into some TE organs (I.E. Bioreactors) is too invasive, therefore out of the question!
Biomarkers are non-invasive and easily observed in fluid around TE organ cells
Assessing TE Organ Health with Surrogate Markers
Kidney Injury Molecule-1 (KIM-1) recognized for it's ability to assess tubule injury
Bringing TE Into the MainstreamAdvocacy is key!Courses on future medical practices requiredTechnology and Future of Medicine course
taught at University of Alberta
Bringing TE Into the Mainstream
Pioneers of TE organs will become experts Will teach future generations
Advocate for TE Organs
Be at the forefront of the new dawn of medicine!
Questions
Thank you for your time